- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02997345
PPROM Registry (Preterm Premature Rupture of Membranes)
Patient Registry for Women Diagnosed With Preterm Premature Rupture of Membranes or PPROM During Pregnancy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Detailed Description
Preterm Premature Rupture of Membranes (pProm) is a factor in 40% of preterm births. The earlier in pregnancy pProm occurs, the greater the potential latency period. Threats to the pregnancy include placental abruption, umbilical cord prolapse, infection, and insufficient pulmonary development, and preterm delivery. Management of pProm may include immediate delivery, induction, or expectant management.
It is still unclear what is considered best practice for the course of treatment in pProm pregnancies and post- delivery care of pProm babies in Neonatal Intensive Care Units (NICU), as well as the long term outcomes of pProm survivors. Unfortunately, there are few recent studies available for review and those that exist often do not reflect the current treatments or innovations that have taken place, especially in neonatal care. Many of the studies available focusing on pProm have very small sample sizes, as well as very short follow-up post-delivery, resulting in a wide range of reported outcomes, especially regarding the morbidity and mortality associated with pProm.
The pProm registry is the first of its kind and will provide a large cohort of data for study. The purpose of this registry is to better understand pregnancies and births impacted by pProm. This includes how pProm is managed in pregnancy and in how pProm neonates are cared for in the NICU; identifying trends in expectant management, and to detect short term and long term outcomes of those affected.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Erin Thatcher
- Phone Number: (740) 837-7766
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80202
- Recruiting
- Www.Aapprom.Org/the-Registry
-
Contact:
- Erin
- Phone Number: 740-837-7766
- Email: erin@aapprom.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Women diagnosed with Preterm Premature Rupture of Membranes (PPROM) prior to 37 weeks of pregnancy
Exclusion Criteria:
- Those without a clinical diagnosis or confirmation of PPROM in pregnancy
- Diagnosis of PROM beyond 37 weeks of pregnancy
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
PPROM (Preterm Premature Rupture of Membranes)
PPROM / Preterm Premature Rupture of Membranes <37 weeks
|
There is no intervention associated with this study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Early Neonatal Mortality Rate
Time Frame: 28 days post delivery
|
28 days post delivery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Stillbirth / Perinatal Mortality Rate
Time Frame: Upon delivery
|
Upon delivery
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Review of Socio-Economic Factors in pProm
Time Frame: Single assessment (observational) at conclusion of pregnancy +30 days, monitored for up to 100 months
|
Single assessment (observational) at conclusion of pregnancy +30 days, monitored for up to 100 months
|
Collaborators and Investigators
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- tpr072013
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Birth
-
Shaare Zedek Medical CenterTerminatedPremature Birth of NewbornIsrael
-
University of VirginiaCompletedPremature Birth of NewbornUnited States
-
Case Western Reserve UniversityCompleted
-
University of California, San FranciscoUniversity of California, San Diego; University of California, Los Angeles; Kaiser...CompletedPremature Birth of NewbornUnited States
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenUnknownPremature Birth of NewbornBelgium
-
Universidad Complutense de MadridCompletedPremature Birth of Newborn
-
Indiana UniversityCompletedPremature LaborUnited States
-
Washington University School of MedicineUniversity of Southern CaliforniaCompletedPremature Birth of NewbornUnited States
-
Vestre Viken Hospital TrustHaukeland University HospitalActive, not recruiting
-
University of ArkansasCompletedPremature Birth of NewbornUnited States
Clinical Trials on There is no intervention associated with this study.
-
University of HaifaRambam Health Care CampusCompletedParkinson DiseaseIsrael
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOcular Hypertension | Glaucoma, Open-AngleCanada
-
University of GeorgiaCompletedHuman PapillomavirusUnited States
-
ProgenaBiomeRecruitingCoronaviridae Infections | COVID-19 | COVID 19 | COVID | Corona Virus Infection | Coronavirus | Gastrointestinal Microbiome | Gut Microbiome | Coronavirus-19 | Coronavirus 19United States
-
University of VirginiaCompletedCancer | Motivation | Smoking BehaviorsUnited States
-
Children's Hospital of PhiladelphiaNational Highway Traffic Safety Administration (NHTSA); Laerdal MedicalCompleted
-
ProgenaBiomeRecruitingGastrointestinal Microbiome | Gut MicrobiomeUnited States
-
Unity Health TorontoSunnybrook Health Sciences Centre; University of British Columbia; Alberta Health... and other collaboratorsCompleted
-
Queens College, The City University of New YorkNational Cancer Institute (NCI)UnknownMortality
-
KU LeuvenCompletedCongenital Heart DiseaseBotswana, United States, Korea, Republic of, Belgium, Sweden, France, Switzerland, Denmark, Pakistan, Norway, Taiwan, Malta, Brazil, Bulgaria, India, Austria, Argentina, Australia, Cameroon, Canada, Chile, Colombia, Ethiopia, Greece, Italy and more